EUVIMEDEUVIMED entdecken
Crossref

Beyond Palliation: Survival Advantage of Definitive Primary Tumor Treatment in Oligometastatic Sarcoma

Y. Han, T. Ho, B.L. Siontis, S.I. Robinson, S. Okuno, K.N. Lee, M.G. Haddock, P.S. Rose, N.N. Laack, R.W. Mutter, M. Welliver

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e148-e149

DOI: 10.1016/j.ijrobp.2026.06.980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Y. Han und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Han, Y., Ho, T., Siontis, B., Robinson, S., Okuno, S., Lee, K., Haddock, M., Rose, P., Laack, N., Mutter, R., & Welliver, M. (2026). Beyond Palliation: Survival Advantage of Definitive Primary Tumor Treatment in Oligometastatic Sarcoma. International Journal of Radiation Oncology*Biology*Physics, 126(1), e148-e149. https://doi.org/10.1016/j.ijrobp.2026.06.980

Vancouver

Han Y, Ho T, Siontis B, Robinson S, Okuno S, Lee K, et al. Beyond Palliation: Survival Advantage of Definitive Primary Tumor Treatment in Oligometastatic Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e148-e149. doi:10.1016/j.ijrobp.2026.06.980

BibTeX
@article{Han2026,
  author = {Han, Y. and Ho, T. and Siontis, B.L. and Robinson, S.I. and Okuno, S. and Lee, K.N. and Haddock, M.G. and Rose, P.S. and Laack, N.N. and Mutter, R.W. and Welliver, M.},
  title = {Beyond Palliation: Survival Advantage of Definitive Primary Tumor Treatment in Oligometastatic Sarcoma},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {e148--e149},
  doi = {10.1016/j.ijrobp.2026.06.980}
}
Kostenlos starten →